We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Phil Horton is the managing director of Dulas Ltd, an international worker-owned co-operative in the field of renewable energy. The company has been providing renewable energy installations for 30 years. The company started by installing solar power in Kenya in 1984, followed by solar powered blood banks in Sudan, pioneering innovative uses of renewable energy.
Dulas develops and delivers renewable energy solutions to a range of clients, including businesses, charities and landowners. In the UK, Dulas is currently working on wind, solar and hydro projects, including installing wind monitoring instruments for the world’s biggest offshore windfarm, while overseas it is mainly focused on its work on solar powered vaccine fridges.
Founder and CEO, Lightpoint Medical
Lightpoint Medical has developed a novel imaging device to improve success in cancer surgery by helping surgeons to remove cancerous tissue, while leaving healthy tissue intact.
The groundbreaking device brings real-time molecular imaging to the operating room, improving health outcomes for cancer patients. The technology is based on the use of Cerenkov luminescence imaging. Dr David Tuch, CEO and Founder, recognised this would have significant diagnostic potential when combined with imaging techniques that observe metabolic processes.
As an intraoperative device, it can be used to guide surgeons so that they can avoid leaving behind microscopic cancerous cells, increasing the likelihood that all target tissue is removed in one surgery. This would prevent patients needing repeat surgeries and minimise any delays to follow-on treatments.
The device can also reduce healthcare costs by making both surgery and follow-on treatment more efficient.
Support from the SME Leaders Programme has allowed David to strengthen skills in strategic marketing and competitive strategy through bespoke training. Since receiving the award in 2017, David’s team has doubled in size to 22 employees. Lightpoint Medical has also raised approximately £4 million in grant funding from organisations in the UK and US and successfully closed a £5 million Series B fundraising round in 2018.
Lightpoint Medical is now working on clinical validation and early commercialisation of its first robotic probe for cancer surgery.
Terrabotics uses powerful algorithmic engines to turn large volumes of satellite imagery into practical 3D maps for industries in the natural resources and energy sectors.
The company uses automated data analysis to rapidly create accurate, high-resolution, 3D digital maps with detailed geospatial information. These comprehensive insights help companies to visualise risks and make smarter decisions. They are designed to support industries that frequently navigate hostile, hazardous areas to improve safety and help them work more efficiently.
Terrabotics’ solutions are used by a growing list of high-profile clients that includes BP, De Beers Group, ExxonMobil and Shell. It plans to further develop its client base through the launch of new products for the oil and gas, mining and metals sectors. In 2018, Terrabotics was awarded a £435,000 contract from the European Space Agency and UK Space to develop Energy SCOUT™, a new solution for oil and gas supply chain monitoring from space.
Gareth Morgan, CEO and Founder, draws on expertise as a scientist and engineer to take a hands-on approach to leadership and strategy development. Supported by the SME Leaders Programme since 2017, Gareth Morgan has participated in training in leadership and business growth. During that time, his team has grown by four staff and there are plans for it to double in size to support Terrabotics’ next phase of growth.
CEO, Adaptix Ltd
A planar (flat) X-ray imaging solution developed by Adaptix Ltd could significantly improve the availability of 3D X-ray diagnosis.
X-ray is the most commonly used imaging technique in healthcare, supporting clinicians in accurately diagnosing disease and trauma. However, most imaging methods involve bulky, expensive equipment, which limits accessibility.
Adaptix aims to correct this with its lightweight, portable X-ray imaging solution. The technology the company uses is more cost effective and energy efficient. It also harnesses the strengths of emerging techniques, such as digital tomosynthesis, to produce higher quality 3D X-ray imagery and increase diagnostic accuracy.
Making X-ray imaging techniques more portable will help ensure that those with previously poor access will be able to benefit from rapid, accurate diagnosis for a range of conditions, from cardiovascular and pulmonary diseases to lung cancer and osteoporosis.
Mark Evans, CEO, has brought extensive expertise in both business management and medical imaging to Adaptix Ltd. Since becoming an SME Leader in 2017, his team has doubled in size to 32 employees. The programme has supported Mark Evans and his management team to scale the business and secure capital – Adaptix has now raised £8 million in equity.
Adaptix has over 50 published patents and will soon launch its first medical and non-clinical products. The company is making an impact in the fields of medical and dental practice. It has also identified further uses for its 3D imaging technology with industrial, security and veterinary applications.
Material corrosion is a cross-sector problem that costs industry potentially $500 billion globally each year. Current anti-corrosion chemicals contain hexavalent chromate, a highly toxic chemical that will be banned from use in the EU from 2019. The need for alternatives is pressing, and Dr Patrick Dodds, CEO and Founder of Hexigone Inhibitors Ltd, has found a novel solution.
Dr Dodds’ anti-corrosion technology is not simply a chemical, but a system of nano-reservoirs that can be incorporated into coatings such as paint. This technology is activated by the chemicals that cause corrosion, triggering the rapid release of a protective agent and essentially making the coated material self-healing.
The aerospace, automotive and shipping industries are among those currently searching for new anti-corrosion solutions. Dr Dodds’ technology has potential to penetrate the £200 billion-dollar protective coating industry thanks to its speed of action and environmental acceptability. It also aims to match current equivalents on price and the length of its guarantee.
Awards from the Worshipful Company of Armourers & Brasiers, Royal Society and Innovate UK have supported proof of concept and development to date. Dr Dodds is now developing this novel technology in collaboration with Tata Steel to manufacture anti-corrosive paint for metals in Europe. Discussions are progressing with other investors, and there has been interest from several multinationals within the paint industry.
Dr Dodds was awarded a 2017 Enterprise Fellowship to support him to develop the business. Next steps involve scaling up the manufacturing process and both long-term and accelerated testing.
Managing Director, Ludwick Precision
Metal fabrication for applications such as laboratory benches and office furniture requires expertise in materials, as well as finely-tuned engineering processes. Ludwick Precision is a specialist in this area, leading fabrication of high-end, bespoke sheet, box and tubular metal solutions.
For 25 years, the Hertfordshire-based company has built up a significant reputation in the design and manufacture of engineered products to meet customers’ bespoke requirements.
Ludwick Precision is a fully integrated manufacturing consultancy, from design and prototyping, to assembly and installation, clients are supported at every stage in the process. This has enabled the company to develop several long-term customer partnerships by consistently delivering projects on time and within budget. Ludwick Precision’s extensive work in the pharmaceutical sector, for example, includes the development and manufacture of the first height-adjustable laboratory bench to be built in the UK.
Ryian Ludwick, Managing Director, has used SME Leaders Programme training to support the business through an expansion programme and his team has grown to 20 people since receiving the award in 2017. In 2019/20, Ryian purchased the company from its main shareholder and he has developed a strategy for Ludwick Precision’s continued growth which includes a focus on the demands of existing customers, and exploring the potential to make products applicable to other niche market sectors.
CEO, Oxford nanoSystems
From air-conditioning units to big data computing, heat-transfer components play a fundamental role in a range of technologies. Oxford nanoSystems is revolutionising the manufacture of these components with a novel coating technology that substantially improves materials’ heat transfer capabilities. This enables the development of lighter products at a reduced cost.
The coating facilitates the production of heat-transfer components that are more efficient and consume less energy thereby improving their environmental sustainability. The flexible coating can be customised and incorporated into existing manufacturing processes, or applied to components after manufacturing.
Before completing his PhD, Alexander Reip was invited to bring his expertise in nanomaterials to Oxford nanoSystems. The company at that point was a new startup and he played a principal role in developing its groundbreaking coating.
Dr Reip is now CEO of the company and leads a team that is dedicated to implementing its product more widely. Supported by the SME Leaders Programme since 2017, Alexander has grown the team from three to 17 staff.
Training in management and leadership has helped Dr Reip to strengthen his entrepreneurial skills and develop a strategy for growth. Oxford nanoSystems has now raised over £2 million in equity funding and over £1.5 million in grant funding. It is now preparing to install its first production plant with a view to accessing new markets that will benefit from improved cooling systems, including the large and growing electronics sector.
GreenSpur Wind has developed a generator that could further reduce the cost of wind energy, making this renewable energy source more cost effective, efficient and sustainable. Many existing machines use scarce and expensive rare earth magnets, which are sourced almost exclusively from China. In contrast, GreenSpur’s patented design makes use of ferrite – an abundant, cheaper alternative type of magnet, which will accelerate deployment. Its low-cost generator can concentrate flux and maximise energy generation, making it the first company to develop a credible option using ferrite magnets for large-scale turbines.
Andrew Hine joined the SME Leaders programme in 2017 when Innovate UK had awarded the company a £1.25 million grant to build a single stage 250kW generator, part of a four-stage 1MW design. This was completed in 2019. A feasibility study is now being undertaken, which will demonstrate how the modular GreenSpur design is capable of being scaled to deliver 15MW-plus configurations.
Now, GreenSpur Wind is working on grant applications and funding that could release millions for further product development. Further investment would allow the company to form an R&D design and development team. The company is also looking for a co-development partner to bring its technology and multi-MW generators to the global wind turbine market.
“The programme has enabled us to transition the business towards an applied engineering strategy. I found the mentoring, both formal and informal, a great support during this transition phase. The networking opportunities provided by the Enterprise Hub were also useful and enabled me to obtain a level of engineering support and advice that had previously been very difficult to access.”
A desire to help create sustainable and resilient cities led Arthur Kay to develop bio-bean, the first company to industrialise the recycling process for spent coffee grounds and transform them into advanced biofuels and biochemicals.
With over 500,000 tonnes of spent coffee grounds going to waste in the UK every year, Arthur recognised them as a valuable, and abundant, resource. They are highly calorific and packed with the right compounds to be a source of sustainable energy.
The company slots neatly into pre-existing waste and energy processes, and works closely with waste-management companies to get spent coffee grounds to their large-scale recycling factory. As a result, the award-winning clean technology company already collects thousands of tonnes yearly from offices, transport hubs and coffee shops, including Costa Coffee.
The used coffee grounds are then transformed into sustainable, high-performance products, such as biomass pellets for heating buildings, and the company’s first consumer product ‘Coffee Logs’ for use at home in stoves and fires.
Rapid growth has enabled the company to build its capacity to recycle up to 50,000 tonnes of used coffee grounds each year, which has significantly reduced the amount that ends up in landfill. By engaging in extensive research, bio-bean now plans to expand its range of advanced carbon-neutral biofuels and biochemicals for commercial use.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Dr Supti Sarkar leads the Technology and Investments Group at PwC. She is responsible for the commercialisation of new tech ventures across the firm, and works with in-house entrepreneurs to get their products market ready.
Supti was formally a management consultant at PA Consulting, where she worked with international and regional governments to support their trade and investment strategies. She was also part of Mayor Sadiq Khan's 2016 delegation to Chicago and New York as part of her role in supporting high growth companies entering the US market for the first time. Supti holds a first class degree and PhD in engineering from University College London and is mum to an eight-year-old daughter.
Dr Douglas C Anderson OBE FREng FRSE has a 40-year business career covering almost every aspect, at every level, of healthcare technology product design and product commercialisation processes.
Having trained in industrial design engineering (Edinburgh Napier University 1974), Douglas progressed from hands on designer to the management of design in the high-tech arena.
Using his consulting company Crombie Anderson as a base for innovation and incubation, he subsequently spun out three other high-tech startup companies, two of which became publicly traded business operating in medical fields.
Douglas was the prime mover in these businesses by leading both the innovation and commercialisation processes, including raising over £40 million in private and institutional funding prior to floatation. Today he is internationally recognised for his innovation and entrepreneurial experience and is a regular keynote speaker at healthcare and business congresses around the world.
In 1990, his five-year-old son Leif suffered a spontaneous retinal detachment that went undetected until it was too late to treat. Douglas was struck by the limited capability of diagnostic tools available to practitioners to examine the retina and decided to address this issue. He built a dedicated research team, which led to the formation of Optos plc, a business funded by Archangel from the outset.
Optos succeeded in designing and patenting a scanning laser ophthalmoscope: the world's first ophthalmic device that enabled eye care professionals to capture a digital ultra wide-field image of the almost the entire retina in a single scan. The new method of examining the retina, marketed as the optomap® Retinal Exam, is now offered as the preferred standard of care by tens of thousands of eye-care specialists globally. Over 200 million optomap® retinal exams have been conducted worldwide and a number of novel diagnostic techniques added to improve the understanding and treatment of a wider range of conditions that have been historically difficult to manage.
In 2006 Douglas was awarded an OBE for services to healthcare. Douglas was elected a Fellow of the Royal Academy of Engineering in 2013.
David is an investor and CEO with companies based on technology and innovation.
After a degree in electrical engineering at the Technion and an MBA from INSEAD, David worked his way to senior management and board level in a wide range of sectors including sustainability, construction, life sciences, manufacturing, mobile telephony, cyber security and software. His broad experience ranges from startups to public companies, from turnaround missions and crisis management to business development and growth.
David is deeply involved in the UK startup space, as a member of UKBAA, VCs, EIS funds and university angel groups, and is an active mentor with the Royal Academy of Engineering and Imperial College London’s IVMS programme. He also serves as a non-executive on the board of directors of Kerur Holdings (a public company), the board of governors of the Technion, as an advisor with the US accelerator Silicon Catalyst and the board of trustees of Hadassah UK.
He believes that success comes from a culture of excellence, a multidisciplinary approach, and that the boundaries between B2B/B2C and startups/LargeCo are increasingly blurred.
"Startups challenge and can defeat established companies. An explosion of new technologies will accelerate this trend. Large companies cannot afford to be on the defensive, they must proactively adopt a startup culture. But startups must also learn to be humble and pragmatic, build structures, communicate at a senior level, and strive to serve all their stakeholders, clients, staff, investors, and society as a whole. A fusion of cultures is now pivotal to success."
Richard joined sustainability investment focused Earth Capital Group in 2009 and has worked both on the group’s investment in investment managers and direct growth company investments, including most recently the fund’s investments in SoftIron and Propelair. He takes a leading role in promoting technology transfer opportunities across the group’s international offices.
Prior to joining Earth Capital, Richard was an Investment Director with IBIS Asset Management Ltd, a London-based captive advisor to a large Caribbean conglomerate. Richard was earlier a senior manager in the London office of L.E.K. Consulting, a global strategy consultancy. During his five years with LEK he provided due diligence advice, in numerous large cap and mid-market private equity deals, and advised corporate clients on corporate strategy, business unit growth strategy, process redesign and cost reduction programmes.
A chartered engineer, his early career included successful engineering, operations and customer support management roles with Ford Motor Company and Visteon Corporation. Richard holds an MBA with Distinction from INSEAD and MEng and MA (First Class) degrees in engineering from the University of Cambridge. He is a chartered member of the Chartered Institute of Securities and Investment, and a Chartered Member of the Institute of Engineering and Technology and a Sainsbury Management Fellow.
Dr Andrew Hosty FREng is an international leader with over 15 years of non-executive board experience and 30 years of executive and management experience, spanning private equity, UK Plc and global blue-chip corporates. He is non-executive director of a companies including: RHI-Magnesita, the global leader in the manufacture and supply of refractories; James Cropper Plc, who create some of the world’s most distinctive and technically advanced paper products; and Rights and Issues Investment Trust Plc, a fund that focuses on small cap UK industrials.
Andrew is Non-Executive Chairman of mOm Incubators ltd, a pre-revenue startup developing low-cost baby incubators for crisis zones. He is also Non-Executive Chairman of Nexeon ltd, a company developing next-generation cathode materials for lithium-ion batteries. From 2016 to 2018 Andrew was the CEO of the Sir Henry Royce Institute, the UK's home of advanced materials research and innovation. He was Chief Operating Officer of Morgan Advanced Materials, and served on the Plc Board as an Executive Director from 2010 to 2016.
From 2013 to 2016 he served on the board
of Consort Medical Plc, a healthcare company focused on developing advanced
delivery technologies, formulation and manufacturing solutions for drugs. He is
a Fellow of the Institute of Materials, holds a PhD from the Faculty of
Engineering at the University of Sheffield and is a Fellow of the Royal Academy
of Engineering (2011).
Chris McIntosh joined Methera Global as CEO in 2017. The company’s vision is to enable the delivery of digital applications to rural and underserved communities worldwide via a resilient constellation of Ka band MEO satellites. He previously spent seven years as CEO of ViaSat UK where he was responsible for the inception and growth of ViaSat’s UK satellite capabilities. Headquartered in the US, ViaSat are renowned as being one of the most disruptive players in the satellite communications and security domain.
Before joining ViaSat Chris was CEO of Stonewood Group, developers of state-of-the-art cyber products and services. He is a retired Lieutenant Colonel from the British Army and has worked within the challenging, high threat cyber and communications environment for over 30 years. He holds a BSc in computer science, MSc in design of computer systems and an MBA. He is a member of the UKspace trade association and the National Security and Resilience Consortium, and is a chartered engineer.
Roy Williamson has been helping companies see how their new innovations can disrupt markets for over 20 years.
For the past six years has been successfully helping early stage companies identify and define their strengths, enhance their uniqueness and develop their storylines to engage investors. Roy’s background is in engineering and cleantech and since 2013, he’s been supporting SMEs and entrepreneurs across a broad area of technologies and innovative business models.
Roy is an aeronautical engineer and started his career at Alstom, developing algorithms and models to estimate hardware costs of power generation gas turbines based purely on, often novel, thermodynamic cycles. He has assessed innovation ecosystems of the UK, published by the Organisation for Economic Co-operation and Development. He has also co-authored guides to support technology developers in the UK automotive sector assess technology readiness levels and help those in the biofuels sector to review pathways for second generation biofuels. He’s appraised novel technology solutions for blue-chip clients, developed proof of concepts and carried out due diligence activities to support investor decision making. He is passionate about the UK and knowledge-intensive companies, from software to deeptech.
Roy is Head of Origination at the Department for International Trade with relationships across the department’s teams, government and the UK’s innovation and investment ecosystem.
Professor Mark Arthur Tooley FREng is the immediate Past President of the Institute of Physics and Engineering in Medicine. He was the Head of the Department of Medical Physics and Bioengineering and Director of Research and Development at the Royal United Hospitals, Bath until 2017 when he retired from full-time NHS work. Since then, he has held several part-time roles. He is a specialist scientific advisor for NHS England, a digital clinical advisor for the West of England Academic Health Science network, and a healthcare technology consultant. He is a registered Consultant Clinical Scientist, an honorary professor at the University of Bath, and a visiting professor at the University of the West of England.
Mark completed his BSc in Electrical and Electronic Engineering at the University of Bath in 1979. He was sponsored by Westinghouse Brake and Signal company for the four years of the course. He then did an MSc and PhD in Medical Physics at the University of London. His MSc thesis was developing a EEG frequency analyser for anaesthesia. For his PhD research, Mark invented (with a cardiologist) an original method for rate-independent diagnosis of cardiac rhythm for implantable devices, which was patented. He spent the rest of his career in Medical Physics and Bioengineering departments, both in hospitals and academia, working along medical colleagues. He has worked at St Bartholomew’s hospital in London, Bristol University, United Bristol healthcare NHS Trust, and the Royal United Hospital, Bath. He is a Fellow of the Royal Academy of Engineering, the Royal College of Physicians, the Institute of Engineering and Technology, the Institute of Physics and Engineering in Medicine, and the Institute of Physics. He is a chartered engineer and chartered scientist. Mark is on the peer-review college of EPSRC, has recently been a member of the Engineering and Physical Sciences Research Council Healthcare Technologies Strategic Advisory Team and the Royal Society Fellowship panel.
Mark has been a long-standing member of the Panel for Biomedical Engineering at the Royal Academy of Engineering (now called the healthcare policy topic group). He was recently a member of the biomedical engineering membership panel, the Policy Committee, and the working group for Systems thinking in healthcare. He has mentored on the enterprise scheme.
Mark’s research interests include innovations in medicine, physics applications in anaesthesia, simulation in medicine, physiological measurement, biological signal processing, measuring the depth of anaesthesia, blood pressure measurement and novel patient monitoring solutions.
Dr Liane Smith FREng founded Intetech Ltd in 1991, winning the Queen’s Award for Innovation in 2012 for its software. She sold the business to Wood Group in 2013 and in 2018 she left to form a new consulting engineering business, Larkton Ltd.
Liane is enthusiastic about the capability of digital technologies to transform businesses, bringing efficiencies, cost reduction, production control and increasing safety. In her last role as Senior Vice President Digital Solutions for Wood, she built the new global service line and defined its strategy roadmap and development plan. Her expertise is in various specialist branches of engineering in the industrial and energy sectors and in software product design and commercialisation, data management, data analysis, and analytics.
“I try to fill in gaps in mentees experience and give them confidence in their decisions. Typically we touch on building strong teams, role and task delegation, agile development, growing sales, exporting and strategy."